Polypharmacy burden and incident epilepsy among older adults in the United States
Epilepsia Open · 2026-08 · 11 (4) · 1370-1381
DOI: 10.1002/epi4.70300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia Open, online erschienen am 02.07.2026. Verfasst von Galen Shearn-Nance und 9 weiteren Autor:innen. Beteiligte Einrichtung: Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Polypharmacy, Epilepsy, Anticonvulsants. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NCCDPHP CDC HHS, CDC HHS.
Abstract (Originalsprache)
Objectives
To estimate the prevalence of polypharmacy among older adults with incident epilepsy and to describe the most common combinations of drug classes filled prior to epilepsy diagnosis. Polypharmacy—the concurrent use of multiple medications—is common in older adults with epilepsy, but little is known about its burden and specific patterns at the time of diagnosis.
Methods
This retrospective longitudinal cohort study included 2 768 656 US Medicare beneficiaries aged 67 and older with Part D coverage. Beneficiaries were epilepsy‐free from 2016 to 2018; 13 819 (0.5%) were newly diagnosed with epilepsy in 2019. The prevalence of polypharmacy and combinations of therapeutic drug classes filled in 2018 were compared between those with and without incident epilepsy using frequent itemset mining and regression models to estimate adjusted rate ratios.
Results
Beneficiaries with incident epilepsy filled prescriptions for a greater number of therapeutic drug classes in the year prior to diagnosis compared with those without epilepsy (median 9 [IQR 5–12] vs. 6 [IQR 3–9]) and were more likely to have filled prescriptions for five or more distinct drug classes (81.4% vs. 63.3%). Antidepressants, gastric medications, and loop diuretics were more prevalent among beneficiaries with incident epilepsy. The combination of calcium channel blockers and antihypertensives was most strongly associated with incident epilepsy after adjustment (adjusted rate ratio 1.54 [99% CI, 1.38–1.71]). Significance Older adults with incident epilepsy experience a high burden of polypharmacy at the time of diagnosis, with nearly 90% prescribed five or more drug classes. Certain drug class combinations, such as antipsychotics and antidepressants, were more frequently observed among those with incident epilepsy. These findings underscore the importance of considering overall polypharmacy burden and specific drug class combinations when initiating epilepsy therapy in older adults. Plain Language Summary Older adults who develop epilepsy often take many medications for other health conditions. In this study of US Medicare beneficiaries, people who were later diagnosed with epilepsy were taking about nine different types of drug classes in the year before diagnosis, compared with about six drug classes among those who did not develop epilepsy. Certain combinations of drug classes—especially those affecting the brain and nervous system—were more common among people who developed epilepsy. These findings show that many older adults have complex medication regimens when epilepsy is first diagnosed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
- Department of Neurology, University of California, Davis, Sacramento, California, USA.
- Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
- Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, Ohio, USA.
- Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Galen Shearn-Nance, Long Vu, Hannah L Fein, Wyatt P Bensken, Jorden G Rieke, Martha Sajatovic, Gena Ghearing, David F Warner, Siran M Koroukian, Nicholas K Schiltz
Förderung
- NIA NIH HHS
- NCCDPHP CDC HHS
- CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Shearn-Nance, G., Vu, L., Fein, H. L., Bensken, W. P., Rieke, J. G., Sajatovic, M., Ghearing, G., Warner, D. F., Koroukian, S. M., & Schiltz, N. K. (2026). Polypharmacy burden and incident epilepsy among older adults in the United States. Epilepsia Open, 11(4), 1370-1381. https://doi.org/10.1002/epi4.70300
Vancouver
Shearn-Nance G, Vu L, Fein HL, Bensken WP, Rieke JG, Sajatovic M, et al. Polypharmacy burden and incident epilepsy among older adults in the United States. Epilepsia Open. 2026;11(4):1370-1381. doi:10.1002/epi4.70300
BibTeX
@article{ShearnNance2026,
author = {Shearn-Nance, Galen and Vu, Long and Fein, Hannah L and Bensken, Wyatt P and Rieke, Jorden G and Sajatovic, Martha and Ghearing, Gena and Warner, David F and Koroukian, Siran M and Schiltz, Nicholas K},
title = {Polypharmacy burden and incident epilepsy among older adults in the United States},
journal = {Epilepsia Open},
year = {2026},
volume = {11},
number = {4},
pages = {1370--1381},
doi = {10.1002/epi4.70300}
}
EUVIMED